Filtered By:
Vaccination: Shingles (Herpes Zoster) Vaccine
This page shows you your search results in order of date. This is page number 10.
Order by Relevance | Date
Total 1783 results found since Jan 2013.
Marketing Two Immunization Services at a Regional Supermarket Chain Pharmacy
Conclusions: The pilot project incorporated personal selling into the dispensing workflow and, although no vaccines were given, provided valuable lessons. The full study demonstrated that personal selling alone and personal selling combined with automated telephone calls were associated with higher vaccine delivery rates.PMID:37368429 | DOI:10.3390/pharmacy11030103
Source: Herpes - June 27, 2023 Category: Infectious Diseases Authors: Megan A Hedden Yifei Liu Peggy G Kuehl Sarah M Oprinovich Source Type: research
Efficacy and effectiveness of Herpes zoster vaccination in adults with diabetes mellitus: a systematic review and meta-analysis of clinical trials and observational studies
CONCLUSIONS: In our meta-analysis of three observational studies LZV showed a 48% effectiveness in reducing HZ incidence in adults with diabetes whereas in a pooled analysis of two RCTs, RZV showed a 91% efficacy. No data are available on the effects of vaccination on the incidence and severity of HZ-related complications among subjects with diabetes.PMID:37340183 | DOI:10.1007/s00592-023-02127-7
Source: Herpes - June 20, 2023 Category: Infectious Diseases Authors: Giovanni Antonio Silverii Alessandra Clerico Riccardo Fornengo Giovanni Gabutti Valeria Sordi Ottavia Peruzzi Silvio Tafuri Edoardo Mannucci Ilaria Dicembrini Source Type: research
Risk of herpes zoster according to past history in the general population: The Japanese Shozu herpes zoster study
J Dermatol. 2023 Jun 19. doi: 10.1111/1346-8138.16828. Online ahead of print.ABSTRACTImmunity is known to persist after vaccination for varicella zoster virus, but the duration of immunity in patients who develop herpes zoster (HZ) remains unknown. To investigate the association between a past history of HZ and its occurrence in the general population. The Shozu HZ (SHEZ) cohort study included data for 12 299 individuals aged ≥50 years with information on their HZ history. Cross-sectional and 3-year follow-up studies were carried out to analyze the associations between a history of HZ (yes <10 years, yes ≥10 years, ...
Source: Herpes - June 19, 2023 Category: Infectious Diseases Authors: Kazuhiro Kawahira Hironori Imano Keiko Yamada Yasuko Mori Hideo Asada Yoshinobu Okuno Koichi Yamanishi Hiroyasu Iso Source Type: research
Post-licensure safety study of new-onset immune-mediated diseases, herpes zoster, and anaphylaxis in adult recipients of HepB-CpG vaccine versus HepB-alum vaccine
CONCLUSIONS: This large post-licensure study did not identify evidence of safety concerns for HepB-CpG compared to HepB-alum for immune-mediated diseases, HZ, or anaphylaxis.PMID:37308363 | DOI:10.1016/j.vaccine.2023.06.004
Source: Vaccine - June 12, 2023 Category: Allergy & Immunology Authors: Bradley Ackerson Lina S Sy Jeff Slezak Lei Qian Kristi Reynolds Runxin Huang Zendi Solano William Towner Sijia Qiu Sarah R Simmons Steven J Jacobsen Katia J Bruxvoort Source Type: research
Proceedings of the expert consensus group meeting on herpes zoster disease burden and prevention in India: An opinion paper
Hum Vaccin Immunother. 2023 Jun 9:2220608. doi: 10.1080/21645515.2023.2220608. Online ahead of print.ABSTRACTHerpes zoster (HZ) is a debilitating viral infection causing a dermatomal vesicular rash. Many known risk factors exist in India and adults >50 years of age may be especially susceptible to HZ. However, HZ is not a notifiable disease in India and data on incidence and disease burden is lacking. An Expert Consensus Group meeting was conducted with experts from relevant specialties to discuss HZ disease, its local epidemiology, and suggestions for implementing HZ vaccination in the Indian healthcare system. Current...
Source: Herpes - June 9, 2023 Category: Infectious Diseases Authors: V Ramasubramanian Agam Vora Youness Lagoubi Nicolas Lecrenier Yashpal Chugh Source Type: research
Causal evidence that herpes zoster vaccination prevents a proportion of dementia cases
medRxiv. 2023 May 25:2023.05.23.23290253. doi: 10.1101/2023.05.23.23290253. Preprint.ABSTRACTThe root causes of dementia are still largely unclear, and the medical community lacks highly effective preventive and therapeutic pharmaceutical agents for dementia despite large investments into their development. There is growing interest in the question if infectious agents play a role in the development of dementia, with herpesviruses attracting particular attention. To provide causal as opposed to merely correlational evidence on this question, we take advantage of the fact that in Wales eligibility for the herpes zoster vacc...
Source: Herpes - June 9, 2023 Category: Infectious Diseases Authors: Markus Eyting Min Xie Simon He ß Simon He ß Pascal Geldsetzer Source Type: research
Proceedings of the expert consensus group meeting on herpes zoster disease burden and prevention in India: An opinion paper
Hum Vaccin Immunother. 2023 Jun 9:2220608. doi: 10.1080/21645515.2023.2220608. Online ahead of print.ABSTRACTHerpes zoster (HZ) is a debilitating viral infection causing a dermatomal vesicular rash. Many known risk factors exist in India and adults >50 years of age may be especially susceptible to HZ. However, HZ is not a notifiable disease in India and data on incidence and disease burden is lacking. An Expert Consensus Group meeting was conducted with experts from relevant specialties to discuss HZ disease, its local epidemiology, and suggestions for implementing HZ vaccination in the Indian healthcare system. Current...
Source: Herpes - June 9, 2023 Category: Infectious Diseases Authors: V Ramasubramanian Agam Vora Youness Lagoubi Nicolas Lecrenier Yashpal Chugh Source Type: research
Causal evidence that herpes zoster vaccination prevents a proportion of dementia cases
medRxiv. 2023 May 25:2023.05.23.23290253. doi: 10.1101/2023.05.23.23290253. Preprint.ABSTRACTThe root causes of dementia are still largely unclear, and the medical community lacks highly effective preventive and therapeutic pharmaceutical agents for dementia despite large investments into their development. There is growing interest in the question if infectious agents play a role in the development of dementia, with herpesviruses attracting particular attention. To provide causal as opposed to merely correlational evidence on this question, we take advantage of the fact that in Wales eligibility for the herpes zoster vacc...
Source: Herpes - June 9, 2023 Category: Infectious Diseases Authors: Markus Eyting Min Xie Simon He ß Simon He ß Pascal Geldsetzer Source Type: research
Do vaccinations influence the development of Alzheimer disease?
This article discusses the potential underlying mechanisms for this apparent protective effect of immunizations against infectious pathogens on the risk of AD; explores the basic and pharmacoepidemiologic evidence for this association, with particular attention paid to important methodological variations among the epidemiologic studies; and reviews the remaining uncertainties regarding the effects of anti-pathogen vaccines on Alzheimer disease and all-cause dementia, with recommendations for future directions to address those uncertainties.PMID:37291109 | DOI:10.1080/21645515.2023.2216625
Source: Herpes - June 8, 2023 Category: Infectious Diseases Authors: Avram S Bukhbinder Yaobin Ling Kristofer Harris Xiaoqian Jiang Paul E Schulz Source Type: research
Disseminated vaccine-induced varicella infection in a kidney transplant recipient
Am J Transplant. 2023 Jun 5:S1600-6135(23)00522-1. doi: 10.1016/j.ajt.2023.05.034. Online ahead of print.ABSTRACTA 33-year-old kidney transplant (KT) recipient presented with a disseminated pruritic, painful, vesicular rash and hepatitis three weeks after receiving a varicella vaccine (VAR). A skin lesion biopsy sent to the Centers for Disease Control and Prevention (CDC) for genotyping confirmed vaccine-strain varicella-zoster virus (VZV) (Oka strain; vOka). The patient was successfully treated with intravenous acyclovir during a prolonged hospital stay. This case supports the contraindication of VAR in adult KT recipient...
Source: Herpes - June 7, 2023 Category: Infectious Diseases Authors: Megan A Berman Richard E Rupp Source Type: research
Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial
Lancet Reg Health West Pac. 2023 Feb 18;34:100707. doi: 10.1016/j.lanwpc.2023.100707. eCollection 2023 May.ABSTRACTBACKGROUND: Despite the success in decreasing varicella-related disease burden, live-attenuated Oka vaccine strain of varicella-zoster virus (vOka) remains neuro-virulence and may establish latency and reactivate, raising safety concerns. Here we aimed to evaluate the safety and immunogenicity of a skin- and neuro-attenuated varicella vaccine candidate (v7D).METHODS: This is a randomized, double-blind, placebo-controlled, dose-escalation and age de-escalation phase 1 clinical trial conducted in Liuzhou, China ...
Source: Herpes - June 7, 2023 Category: Infectious Diseases Authors: Zhao-Jun Mo Shou-Jie Huang Ling-Xian Qiu Chang-Gui Li Xiao-Juan Yu Ming-Qiang Li Zhen Chen Guo-Hua Zhong De-Quan Pan Li-Rong Huang Bang-Jun Lv Xue-Lian Cui Qiao-Qiao Song Ji-Zong Jia Jin-Le Han Wei Wang Hua Zhu Tong Cheng Ying-Ying Su Yi-Min Li Xiang-Zhon Source Type: research
